Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Neurolife Laboratory, Rio de Janeiro, Brazil.
Ann Neurol. 2021 May;89(5):1041-1045. doi: 10.1002/ana.26041. Epub 2021 Feb 24.
Patients with coronavirus disease 2019 (COVID-19) can present with distinct neurological manifestations. This study shows that inflammatory neurological diseases were associated with increased levels of interleukin (IL)-2, IL-4, IL-6, IL-10, IL-12, chemokine (C-X-C motif) ligand 8 (CXCL8), and CXCL10 in the cerebrospinal fluid. Conversely, encephalopathy was associated with high serum levels of IL-6, CXCL8, and active tumor growth factor β1. Inflammatory syndromes of the central nervous system in COVID-19 can appear early, as a parainfectious process without significant systemic involvement, or without direct evidence of severe acute respiratory syndrome coronavirus 2 neuroinvasion. At the same time, encephalopathy is mainly influenced by peripheral events, including inflammatory cytokines. ANN NEUROL 2021;89:1041-1045.
新型冠状病毒病 2019(COVID-19)患者可出现明显的神经系统表现。本研究表明,炎症性神经系统疾病与脑脊液中白细胞介素(IL)-2、IL-4、IL-6、IL-10、IL-12、趋化因子(C-X-C 基序)配体 8(CXCL8)和 CXCL10 水平升高有关。相反,脑病与血清中白细胞介素 6、CXCL8 和活性肿瘤生长因子β1 水平升高有关。COVID-19 患者的中枢神经系统炎症综合征可早期出现,表现为无明显全身受累的副感染过程,或无严重急性呼吸综合征冠状病毒 2 神经入侵的直接证据。同时,脑病主要受包括炎症细胞因子在内的外周事件影响。ANN NEUROL 2021;89:1041-1045。